Literature DB >> 23376683

Altered Purkinje cell miRNA expression and SCA1 pathogenesis.

Edgardo Rodriguez-Lebron1, Gumei Liu, Megan Keiser, Mark A Behlke, Beverly L Davidson.   

Abstract

Spinocerebellar ataxia type 1 (SCA1) is a dominantly inherited neurodegenerative disorder caused by polyglutamine repeat expansions in Ataxin-1. Recent evidence supports a role for microRNAs (miRNAs) deregulation in SCA1 pathogenesis. However, the extent to which miRNAs may modulate the onset, progression or severity of SCA1 remains largely unknown. In this study, we used a mouse model of SCA1 to determine if miRNAs are misregulated in pre- and post-symptomatic SCA1 cerebellum. We found a significant alteration in the steady-state levels of numerous miRNAs prior to and following phenotypic onset. In addition, we provide evidence that increased miR-150 levels in SCA1 Purkinje neurons may modulate disease pathogenesis by targeting the expression of Rgs8 and Vegfa. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23376683      PMCID: PMC3629010          DOI: 10.1016/j.nbd.2013.01.019

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  39 in total

1.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

2.  MicroRNA targeting specificity in mammals: determinants beyond seed pairing.

Authors:  Andrew Grimson; Kyle Kai-How Farh; Wendy K Johnston; Philip Garrett-Engele; Lee P Lim; David P Bartel
Journal:  Mol Cell       Date:  2007-07-06       Impact factor: 17.970

Review 3.  Trinucleotide repeat disorders.

Authors:  Harry T Orr; Huda Y Zoghbi
Journal:  Annu Rev Neurosci       Date:  2007       Impact factor: 12.449

Review 4.  Genetics of the dominant ataxias.

Authors:  Dineke S Verbeek; Bart P C van de Warrenburg
Journal:  Semin Neurol       Date:  2012-01-21       Impact factor: 3.420

5.  MicroRNA pathways modulate polyglutamine-induced neurodegeneration.

Authors:  Julide Bilen; Nan Liu; Barrington G Burnett; Randall N Pittman; Nancy M Bonini
Journal:  Mol Cell       Date:  2006-10-06       Impact factor: 17.970

6.  Climbing fiber activity reduces 14-3-3-θ regulated GABA(A) receptor phosphorylation in cerebellar Purkinje cells.

Authors:  Z Qian; M Micorescu; V Yakhnitsa; N H Barmack
Journal:  Neuroscience       Date:  2011-11-17       Impact factor: 3.590

Review 7.  Brain pathology of spinocerebellar ataxias.

Authors:  Kay Seidel; Sonny Siswanto; Ewout R P Brunt; Wilfred den Dunnen; Horst-Werner Korf; Udo Rüb
Journal:  Acta Neuropathol       Date:  2012-06-09       Impact factor: 17.088

8.  The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila.

Authors:  Nan Liu; Michael Landreh; Kajia Cao; Masashi Abe; Gert-Jan Hendriks; Jason R Kennerdell; Yongqing Zhu; Li-San Wang; Nancy M Bonini
Journal:  Nature       Date:  2012-02-15       Impact factor: 49.962

9.  Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression.

Authors:  Florence Allantaz; Donavan T Cheng; Tobias Bergauer; Palanikumar Ravindran; Michel F Rossier; Martin Ebeling; Laura Badi; Bernhard Reis; Hans Bitter; Matilde D'Asaro; Alberto Chiappe; Sriram Sridhar; Gonzalo Duran Pacheco; Michael E Burczynski; Denis Hochstrasser; Jacky Vonderscher; Thomas Matthes
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

Review 10.  Cell biology of spinocerebellar ataxia.

Authors:  Harry T Orr
Journal:  J Cell Biol       Date:  2012-04-16       Impact factor: 10.539

View more
  19 in total

1.  miR-25 alleviates polyQ-mediated cytotoxicity by silencing ATXN3.

Authors:  Fengzhen Huang; Li Zhang; Zhe Long; Zhao Chen; Xuan Hou; Chunrong Wang; Huirong Peng; Junling Wang; Jiada Li; Ranhui Duan; Kun Xia; De-Maw Chuang; Beisha Tang; Hong Jiang
Journal:  FEBS Lett       Date:  2014-11-20       Impact factor: 4.124

2.  Broad therapeutic benefit after RNAi expression vector delivery to deep cerebellar nuclei: implications for spinocerebellar ataxia type 1 therapy.

Authors:  Megan S Keiser; Ryan L Boudreau; Beverly L Davidson
Journal:  Mol Ther       Date:  2013-12-12       Impact factor: 11.454

3.  Gene co-expression network analysis for identifying modules and functionally enriched pathways in SCA2.

Authors:  Lance T Pflieger; Warunee Dansithong; Sharan Paul; Daniel R Scoles; Karla P Figueroa; Pratap Meera; Thomas S Otis; Julio C Facelli; Stefan M Pulst
Journal:  Hum Mol Genet       Date:  2017-08-15       Impact factor: 6.150

4.  Altered expression of miR-202 in cerebellum of multiple-system atrophy.

Authors:  Soon-Tae Lee; Kon Chu; Keun-Hwa Jung; Jae-Jun Ban; Woo-Seok Im; Hee-Yeon Jo; Ji-Hyun Park; Ji-Yeon Lim; Jung-Won Shin; Jangsup Moon; Sang Kun Lee; Manho Kim; Jae-Kyu Roh
Journal:  Mol Neurobiol       Date:  2014-07-01       Impact factor: 5.590

5.  Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease.

Authors:  Vitor Carmona; Janete Cunha-Santos; Isabel Onofre; Ana Teresa Simões; Udaya Vijayakumar; Beverly L Davidson; Luís Pereira de Almeida
Journal:  Mol Ther       Date:  2017-02-22       Impact factor: 11.454

6.  Wide Profiling of Circulating MicroRNAs in Spinocerebellar Ataxia Type 7.

Authors:  Verónica M Borgonio-Cuadra; Claudia Valdez-Vargas; Sandra Romero-Córdoba; Alfredo Hidalgo-Miranda; Yessica Tapia-Guerrero; César M Cerecedo-Zapata; Oscar Hernández-Hernández; Bulmaro Cisneros; Jonathan J Magaña
Journal:  Mol Neurobiol       Date:  2019-02-05       Impact factor: 5.590

7.  Broad distribution of ataxin 1 silencing in rhesus cerebella for spinocerebellar ataxia type 1 therapy.

Authors:  Megan S Keiser; Jeffrey H Kordower; Pedro Gonzalez-Alegre; Beverly L Davidson
Journal:  Brain       Date:  2015-10-21       Impact factor: 13.501

Review 8.  Regulators of G protein signaling in cardiovascular function during pregnancy.

Authors:  Katherine J Perschbacher; Guorui Deng; Rory A Fisher; Katherine N Gibson-Corley; Mark K Santillan; Justin L Grobe
Journal:  Physiol Genomics       Date:  2018-04-27       Impact factor: 3.107

Review 9.  Current understanding of the role of microRNAs in spinocerebellar ataxias.

Authors:  Edyta Koscianska; Wlodzimierz J Krzyzosiak
Journal:  Cerebellum Ataxias       Date:  2014-08-07

Review 10.  Small non-coding RNAs add complexity to the RNA pathogenic mechanisms in trinucleotide repeat expansion diseases.

Authors:  Eulàlia Martí; Xavier Estivill
Journal:  Front Mol Neurosci       Date:  2013-12-03       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.